Adjuvant Therapy Options in Melanoma

Navigating treatment choices in high-risk early-stage melanomaПодробнее

Navigating treatment choices in high-risk early-stage melanoma

Emerging Neoadjuvant and Adjuvant Therapies for Locally Advanced MelanomaПодробнее

Emerging Neoadjuvant and Adjuvant Therapies for Locally Advanced Melanoma

How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof WarnerПодробнее

How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner

Current Treatment Landscape for Cutaneous MelanomaПодробнее

Current Treatment Landscape for Cutaneous Melanoma

Immunotherapy at ASCO24: NADINA and Other Key StudiesПодробнее

Immunotherapy at ASCO24: NADINA and Other Key Studies

2024 Melanoma Research Victoria Scientific Exchange MeetingПодробнее

2024 Melanoma Research Victoria Scientific Exchange Meeting

Assessing the role of adjuvant therapy in the real-world setting for stage III melanomaПодробнее

Assessing the role of adjuvant therapy in the real-world setting for stage III melanoma

Living With Melanoma Symposium with Providence Cancer Institute OregonПодробнее

Living With Melanoma Symposium with Providence Cancer Institute Oregon

Neoadjuvant daromun is an effective and safe therapeutic option for resectable, locally advanced...Подробнее

Neoadjuvant daromun is an effective and safe therapeutic option for resectable, locally advanced...

The Evolving Role of Surgery in Melanoma ManagementПодробнее

The Evolving Role of Surgery in Melanoma Management

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvan...Подробнее

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvan...

Melanoma Skin Cancer Webinar -Management of Stage 2 and 3 MelanomaПодробнее

Melanoma Skin Cancer Webinar -Management of Stage 2 and 3 Melanoma

Systemic Therapy for Melanoma Guideline UpdateПодробнее

Systemic Therapy for Melanoma Guideline Update

Adjuvant Treatment in Melanoma: Recent AdvancesПодробнее

Adjuvant Treatment in Melanoma: Recent Advances

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable MelanomaПодробнее

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III MelanomaПодробнее

Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma

FDA D.I.S.C.O.: Nivolumab for adjuvant treatment of patients with melanomaПодробнее

FDA D.I.S.C.O.: Nivolumab for adjuvant treatment of patients with melanoma

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for MelanomaПодробнее

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

What is Metastatic Melanoma Adjuvant Therapy? Tanner Deason's Journey with Cancer ContinuesПодробнее

What is Metastatic Melanoma Adjuvant Therapy? Tanner Deason's Journey with Cancer Continues

Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case PresentationПодробнее

Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation